AR vs BP

The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline stable health, while the absence of an Altman Z-Score prevents a clear distress risk assessment. The stock trades above the Graham Number ($31.83) at $34.29, suggesting a slight premium, though below the analyst target of $43.30. Solid revenue growth (13.4% YoY) and strong gross margins (67.0%) are offset by weak earnings consistency, deteriorating recent EPS trends, and poor liquidity metrics. Analysts recommend a 'buy', but insider sentiment is neutral with no recent transactions.

BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.